Literature DB >> 31591775

Editorial: potassium-competitive acid blockers for acid-related diseases-tegoprazan, a new kid on the block.

Carmelo Scarpignato1,2,3, Richard H Hunt4.   

Abstract

Entities:  

Year:  2019        PMID： 31591775     DOI： 10.1111/apt.15480

Source DB:  PubMed          Journal:  Aliment Pharmacol Ther        ISSN： 0269-2813            Impact factor:   8.171


× No keyword cloud information.
  4 in total

Review 1.  Update on the Management of Helicobacter pylori Infection.

Authors:  Nasir Saleem; Colin W Howden
Journal:  Curr Treat Options Gastroenterol       Date:  2020-07-17

2.  Randomised clinical trial: tegoprazan, a novel potassium-competitive acid blocker, or lansoprazole in the treatment of gastric ulcer.

Authors:  Yu Kyung Cho; Myung-Gyu Choi; Suck Chei Choi; Kee Myung Lee; Tae Oh Kim; Soo-Heon Park; Jeong Seop Moon; Yun Jeong Lim; Dae Hwan Kang; Gab Jin Cheon; Gwang Ho Baik; Kyoung Oh Kim; Kwang Bum Cho; Jin Seok Jang; Jong-Jae Park; Byoung Kwan Son; Hye-Kyung Jung; Byung-Wook Kim; Sung Kuk Kim; Soo Teik Lee; Jae Myung Cha; Ah Rong Kim; Eun Ji Kim; Hyun Wook Park; Geun Seog Song
Journal:  Aliment Pharmacol Ther       Date:  2020-07-23       Impact factor: 8.171

3.  Night-time gastric acid suppression by tegoprazan compared to vonoprazan or esomeprazole.

Authors:  Eunsol Yang; Seokuee Kim; Bongtae Kim; Boram Kim; Yechan Kim; Sung Sup Park; Geun Seog Song; Kyung-Sang Yu; In-Jin Jang; SeungHwan Lee
Journal:  Br J Clin Pharmacol       Date:  2022-02-23       Impact factor: 3.716

4.  Efficacy of Tegoprazan for Improving the Susceptibility of Antimicrobial Agents against Antibiotic-Resistant Helicobacter pylori.

Authors:  Jung Won Lee; Nayoung Kim; Ryoung Hee Nam; Jeong Eun Yu; Joo Hee Son; Sun Min Lee; Dong Ho Lee
Journal:  Gut Liver       Date:  2021-01-15       Impact factor: 4.519
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.